Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-08 Cohen Fred E Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-08 BUTITTA CYNTHIA M Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-08 Belldegrun Arie Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-06-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,042 18,753
2020-06-04 Schoenberg Mark Chief Medical Officer Sale −349 $27.51 $10K 18,404
2020-06-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −1,042 2,083
2020-06-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 166,272
2020-06-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 167,341
2020-05-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +1,041 7,437
2020-05-20 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −358 $25.07 $9K 7,079
2020-05-20 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −1,041 5,208
2020-05-12 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +35,229 157,465
2020-05-12 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −35,229 176,148
2020-05-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,808 157,465
2020-05-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,808 176,148
2020-04-27 Schoenberg Mark Chief Medical Officer Sale −70 $24.35 $2K 17,711
2020-04-27 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −141 $24.35 $3K 6,396
2020-04-27 Mullennix Stephen Chief Operating Officer Sale −145 $24.35 $4K 10,084
2020-04-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +208 17,781
2020-04-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −208 1,459

Page 21 of 25 · 496 trades